Target intelligence / Profile preview

RNA, U6 small nuclear 317, pseudogene (RNU6-317P)

Target
RNU6-317P
Molecular classification
Other (Pseudogene; derived from small nuclear RNA family)
01

Overview

RNU6-317P (RNA, U6 small nuclear 317, pseudogene) is a pseudogene closely related to the U6 small nuclear RNA gene in humans, but it does not encode a functional protein and is not considered a therapeutic target. It is a human pseudogene derived from U6 small nuclear RNA (snRNA) sequence. U6 snRNA is an essential, highly conserved component of the spliceosome, responsible for catalyzing intron removal from pre-mRNA during RNA splicing in eukaryotes. However, RNU6-317P itself is a non-functional copy (pseudogene) and does not participate in splicing or other known cellular processes. Human genomes contain many U6-derived pseudogenes, thought to have arisen by duplication and mutation. While most pseudogenes do not produce functional products, some pseudogenes occasionally generate non-coding RNAs that can be transcribed but generally have limited or no biological activity. RNU6-317P does not currently have any established clinical or research role, is not a therapeutic target, and lacks evidence of disease involvement or drug interaction. It is not a functional gene or receptor. It is not a recognized drug target and does not have biological functions or disease associations ascribed to it. U6 pseudogenes are common in vertebrate genomes and generally serve no direct function.

Other names
RNU6-317PU6 snRNA pseudogeneRNA, U6 small nuclear 317, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 317, pseudogene (RNU6-317P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 317, pseudogene (RNU6-317P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call